262 results on '"Maconi, A"'
Search Results
2. The learning curve for using intestinal ultrasonography
3. Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease
4. Strictureplasties performed by laparoscopic approach for complicated Crohn's disease. A prospective, observational, cohort study
5. Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
6. OC.03.11: FACTORS CORRELATED WITH TRANSMURAL HEALING IN PATIENTS WITH CROHN'S DISEASE IN LONG-TERM CLINICAL REMISSION ON ANTI-TNF MEDICATION
7. BOC.02.8: DEFINING DIAGNOSTIC ULTRASONOGRAPHIC PARAMETERS IN ULCERATIVE COLITIS: A LONGITUDINAL PROSPECTIVE MULTICENTER STUDY
8. Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice
9. Complications and early mortality in percutaneous endoscopic gastrostomy placement in lombardy: A multicenter prospective cohort study
10. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study
11. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
12. OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
13. T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY
14. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015
15. The impact of symptoms, irritable bowel syndrome pattern and diagnostic investigations on the diagnostic delay of Crohn's disease: A prospective study
16. T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM 'LONG VEDO' ITALIAN MULTICENTER STUDY
17. OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
18. Evaluation of hands-on training in colonoscopy: Is a computer-based simulator useful?
19. T.04.5 ARE THE ESGE COMPETENCE STANDARDS FOR OPTICAL DIAGNOSIS OF DIMINUTIVE COLORECTAL LESIONS ACHIEVABLE IN ULCERATIVE COLITIS? THE ROLE OF DIAGNOSTIC CRITERIA
20. OC.02.4 PREVALENCE AND PREDICTORS OF NEOPLASTIC AND NONNEOPLASTIC POLYPOID AND NON-POLYPOID LESIONS IN ULCERATIVE COLITIS IN THE ERA OF POWERED ENDOSCOPY: A SYSTEMATIC REAL-LIFE STUDY ON 1120 LESIONS
21. OC.09.7 THE IMPACT OF BIOLOGIC THERAPIES ON EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE OBSERVATIONAL STUDY
22. AF.114 A COMPARATIVE AUDIT OF TWO SURVEILLANCE STRATEGIES FOR THE CHARACTERIZATION OF POLYPOID AND NON-POLYPOID LESIONS IN ULCERATIVE COLITIS WITH OR WITHOUT POWERED ENDOSCOPY AND MUCOSAL PATTERN CLASSIFICATIONS
23. OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
24. Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease
25. OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
26. Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
27. T.04.5 ARE THE ESGE COMPETENCE STANDARDS FOR OPTICAL DIAGNOSIS OF DIMINUTIVE COLORECTAL LESIONS ACHIEVABLE IN ULCERATIVE COLITIS? THE ROLE OF DIAGNOSTIC CRITERIA
28. OC.02.4 PREVALENCE AND PREDICTORS OF NEOPLASTIC AND NONNEOPLASTIC POLYPOID AND NON-POLYPOID LESIONS IN ULCERATIVE COLITIS IN THE ERA OF POWERED ENDOSCOPY: A SYSTEMATIC REAL-LIFE STUDY ON 1120 LESIONS
29. Imaging of perianal Crohn's disease
30. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study
31. “Cervia II Working Group Report 2006”: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy
32. OC.08.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS: AN INTERNATIONAL STUDY
33. T04.01.9 IMPACT OF ULCERATIVE COLITIS AND ITS ASSOCIATED DISEASE BURDEN ON ITALIAN PATIENTS: THE FIRST-YEAR ANALYSIS OF THE ICONIC STUDY
34. OC.09.7 THE IMPACT OF BIOLOGIC THERAPIES ON EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE OBSERVATIONAL STUDY
35. AF.114 A COMPARATIVE AUDIT OF TWO SURVEILLANCE STRATEGIES FOR THE CHARACTERIZATION OF POLYPOID AND NON-POLYPOID LESIONS IN ULCERATIVE COLITIS WITH OR WITHOUT POWERED ENDOSCOPY AND MUCOSAL PATTERN CLASSIFICATIONS
36. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection
37. OC.08.3 THE 'DICA' ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS: AN INTERNATIONAL STUDY
38. T04.01.9 IMPACT OF ULCERATIVE COLITIS AND ITS ASSOCIATED DISEASE BURDEN ON ITALIAN PATIENTS: THE FIRST-YEAR ANALYSIS OF THE ICONIC STUDY
39. P.02.12 PREDICTIVE VALUE OF THE 'DICA' ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
40. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
41. P.07.37 ROLE OF ULTRASOUND ELASTOGRAPHY FOR DETECTION OF FIBROTIC BOWEL STRICTURE IN PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
42. P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
43. OC.12.1 REAL-LIFE EFFECTIVENESS OF USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CONCOMITANT PSORIASIS OR PSORIATIC ARTHRITIS: AN IG-IBD STUDY
44. OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
45. Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn's disease
46. Infliximab in treatment of Crohn's disease: the Milan experience
47. Treatment of Helicobacter pylori infection. indications and regimens: an update
48. P.07.5 SMOKER AND EX-SMOKER PATIENTS AFFECTED BY CROHN'S DISEASE: ARE THEY SO DIFFERENT?
49. P.05.7 EPIDEMIOLOGY OF DIVERTICULAR DISEASE OF THE COLON: A PRELIMINARY ANALYSIS FROM THE INTERNATIONAL 'DICA' PROSPECTIVE STUDY
50. OC.03.3 THE 'DICA' ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.